California Governor says that his state will “go all in” to expand access to psychedelics in therapeutic settings. He explains that it is a matter of “landing on what exactly the language is” regarding psychedelics.
Talking to Shawn Ryan about military issues and veteran’s rights, the Governor of California spoke with Shawn Ryan. Gavin Newsom, a Democrat from California, said that he supports the medically-supervised use of psychoactive substances. However he is still concerned about their commercialization.
Newsom explained that “the downside is that I have many entrepreneurial friends who are keen to enter this market.” I’m cautious because capitalism is moving this space in a different direction from where we would like to take it.
The governor in 2023 vetoed a broad psychedelics proposal that included provisions to legalize low-level possession of substances such as psilocybin.
In his then vetoed message, he urged lawmakers to submit a new law the next year that would establish guidelines for controlled therapeutic access to drugs like psychedelics. Additionally, the bill should also consider “potential framework” for decriminalization.
Newsom wrote in his veto statement that, “A combination of peer-reviewed research and my own powerful anecdotes have convinced me to support the new opportunity to tackle mental health with psychedelic medications like those covered by this bill.” “Psychedelics are proven to help people with certain mental conditions, such as depression and PTSD. They also relieve those who have addictive personalities. California will lead the way in this new exciting frontier.
However, since then, the progress made in the state on reforming psychedelics has been slow.
Last year, for example, a Senate committee effectively killed a bill to legalize psychedelic service centers where adults 21 and older could access psilocybin, MDMA, mescaline and DMT in a supervised environment with trained facilitators. Newsom voiced his concerns in an earlier veto of the bill, and it was designed to address those concerns.
A bipartisan Senate bill, which would have established a pilot psilocybin program for veterans of the military and ex-first responders was also rejected by a Senate Committee in May.
Ryan revealed that his personal experience with ibogaine in Mexico was positive. He said, “I haven’t drunk in three years.” When I took ibogaine, it was like switching on a light.
Newsom responded, “We are all in,” but also added that it is the details which make the difference.
Newsom, pointing to the legalization of cannabis in California, which he supported, said policymakers at that time “believed” in a “regulatory market,” but added that “officials haven’t yet killed the black-market” and taxes “create lots of raw emotions.”
Newsom also signed into law a separate bill last year that streamlined the application process for studies on marijuana and psychedelics.
In the meantime, as for cannabis taxes, earlier this month, senators from various states advanced a measure to put an end to a recently enacted tax hike on marijuana-related products.
Members of the Senate Revenue and Taxation Committee voted 5–0 to approve the Assembly-passed measure from Assemblymember Matt Haney (D) that would delay the tax increase by five years.
Meanwhile, California officials are inviting research proposals for a second round of grants under a program meant to better educate the public on the state’s marijuana law and help policymakers make informed decisions on the issue.
Last month, the Governor’s Office of Business and Economic Development (GO-Biz) announced the recipients of over $52 million in community reinvestment grants to nonprofits and local health departments, also funded by marijuana tax revenue.
That marked the seventh round of cannabis-funded California Community Reinvestment Grants (CalCRG) under the state program.
California’s legalization of marijuana has led to the creation of a variety of grant programs that are geared towards addressing consequences of prohibition, and trying to foster a well-regulated industry.
California’s Supreme Court separately delivered a victory for the state’s marijuana program last month, rescinding a lower court ruling in a case that suggested federal prohibition could be used locally to undermine the cannabis market.
The state Supreme Court ruling also came just weeks after California officials unveiled a report on the current status and future of the state’s marijuana market—with independent analysts hired by regulators concluding that the federal prohibition on cannabis that prevents interstate commerce is meaningfully bolstering the illicit market.
The governor did sign a bill in 2022 that would have empowered him to enter into interstate cannabis commerce agreements with other legal states, but that power was incumbent upon federal guidance or an assessment from the state attorney general that sanctioned such activity.
CostaPPR. Image by CostaPPR.
MEDCAN24 could not exist without readers’ support. Consider a Patreon subscription if our marijuana advocacy journalism is what you use to keep informed.
